Abstract 12903: Frailty Did Not Diminish the Prognostic Advantage of Guideline-Directed Medical Therapy in Elderly Patients With Heart Failure (Multicentral Cohort Study)

Takuro Abe,Kentaro Jujo,Katsumi Saito,Saito Kazuya,Hiroshi Saito,Iwata Kentaro,Masaaki Konishi,Takeshi Kitai,Takatoshi Kasai,Hiroshi Wada,Shin-ichi Momomura,Nobuyuki Kagiyama,Kentaro Kamiya,Yamashita Masashi,Nobuaki Hamazaki,Nozaki Kohei,Emi Maekawa,Junya Ako,Yuya Matsue

Abstract 12903: Frailty Did Not Diminish the Prognostic Advantage of Guideline-Directed Medical Therapy in Elderly Patients With Heart Failure (Multicentral Cohort Study)

2021

Takuro Abe
Kentaro Jujo
Katsumi Saito
Saito Kazuya
Hiroshi Saito
Iwata Kentaro
Masaaki Konishi
Takeshi Kitai
Takatoshi Kasai
Hiroshi Wada
Shin-ichi Momomura
Nobuyuki Kagiyama
Kentaro Kamiya
Yamashita Masashi
Nobuaki Hamazaki
Nozaki Kohei
Emi Maekawa
Junya Ako
Yuya Matsue

Introduction: Numerous previous trials revealed that the effectiveness of guideline-directed medical therapy (GDMT) including beta-blockers (BB) and renin-angiotensin system inhibitors (RASi) in pa...

Keywords:

Beta blocker
Guideline
ACE inhibitor
Internal medicine
Heart failure
Cohort study
medical therapy
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations